S-Space College of Medicine/School of Medicine (의과대학/대학원) Pediatrics (소아과학전공) Journal Papers (저널논문_소아과학전공)
Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia
- Choi, Jaewon; Hwang, Yu Kyeong; Sung, Ki Woong; Lee, Soo Hyun; Yoo, Keon Hee; Jung, Hye Lim; Koo, Hong Hoe; Kim, Hee-Jin; Kang, Hyong Jin; Shin, Hee Young; Ahn, Hyo Seop
- Issue Date
- American Society of Hematology
- Blood 2007;109:471-477
- Adaptor Proteins, Signal Transducing/biosynthesis/*genetics; Adolescent; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cell Proliferation/drug effects; Child; Child, Preschool; Female; Follow-Up Studies; *Gene Expression Profiling; Gene Expression Regulation, Leukemic/*genetics; Humans; Infant; Inhibitor of Apoptosis Proteins/biosynthesis/*genetics; Male; Methylprednisolone/pharmacology; Molecular Sequence Data; Neoplasm Proteins/biosynthesis/*genetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/drug; therapy/*genetics; Predictive Value of Tests; Prognosis; RNA, Messenger/biosynthesis/genetics; Recurrence; Reverse Transcriptase Polymerase Chain Reaction/methods; Survival Rate; Treatment Outcome; Tumor Markers, Biological/*genetics
- Livin, a member of the inhibitor of apoptosis proteins, has been considered to be a poor prognostic marker in malignancies. However, little is known about the clinical relevance of Livin expression in childhood acute lymphoblastic leukemia (ALL). In this study, the expression of Livin was analyzed in 222 patients with childhood ALL using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate a possible association with the clinical features at diagnosis and treatment outcomes. Both Livin expression rates and expression levels were higher in patients with favorable prognostic factors. The expression rate was also higher in patients with a favorable day 7 bone marrow response to induction chemotherapy (P<.001). The Livin expression was related to the absence of relapse (P<.001). Similarly, the relapse-free survival rate (+/-95% CI) was higher in patients with Livin expression than in patients without Livin expression (97.9%+/-4.0% versus 64.9%+/-11.8%, P<.001). Multivariate analysis for relapse-free survival demonstrated that Livin expression was an independent favorable prognostic factor in childhood ALL (P=.049). This study suggests that Livin expression is a novel prognostic marker in childhood ALL and thus needs to be incorporated into the patient stratification and treatment protocols.
- 0006-4971 (Print)
- Files in This Item: There are no files associated with this item.